Featured Peptides
CJC-1295 + Ipamorelin 5mg/5mg (No DAC) | ≥99% Purity | UK Research Blend
CJC-1295 (No DAC) + Ipamorelin 5mg/5mg research blend, 10mg co-lyophilised, ≥99% purity, HPLC + MS verified. UK batch-tested. Research only.
🚚 Free UK shipping over £100 · dispatched next business day ·
- ✓ Independently HPLC + MS verified — per-batch Certificate of Analysis
- ✓ Pay by Bank (Fena / Wallid) or bank transfer (BACS)
⚠ For laboratory research use only. Not for human or veterinary use. Must be 21+ to purchase.
CJC-1295 + Ipamorelin 5mg/5mg combines 5mg of CJC-1295 without DAC and 5mg of Ipamorelin in a single co-lyophilised vial for laboratory research. Every batch is HPLC-verified to ≥99% purity with the identity of both peptides confirmed by mass spectrometry, and independently tested by an ISO 17025 accredited third-party laboratory. It is supplied strictly for in-vitro research use only.
CJC-1295 + Ipamorelin 5mg/5mg at a Glance
| Product | CJC-1295 (No DAC) + Ipamorelin 5mg/5mg |
| Total peptide content | 10mg per vial |
| Composition | CJC-1295 without DAC 5mg, Ipamorelin 5mg |
| Form | Co-lyophilised powder (requires reconstitution) |
| CJC-1295 (No DAC) | Modified GRF (1–29), C152H252N44O42, ≈3,367.9 Da |
| Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2, C38H49N9O5, ≈711.9 Da |
| Purity | ≥99% (HPLC) |
| Identity | Both peptides confirmed by mass spectrometry |
| Testing | ISO 17025 accredited third-party laboratory, batch-specific certificate |
| Storage | Lyophilised: −20°C long term. Reconstituted: 2–8°C |
| Intended use | Research use only. Not for human or veterinary use. |
What Is the CJC-1295 + Ipamorelin Blend?
This blend pairs two peptides that act on different arms of the growth hormone axis. CJC-1295 without DAC, also known as Modified GRF (1–29), is a 29-residue GHRH analogue carrying four amino-acid substitutions that protect it from enzymatic cleavage. Ipamorelin is a five-residue selective agonist at the ghrelin receptor (GHS-R1a). Because GHRH-receptor and ghrelin-receptor signalling converge on the pituitary somatotroph, the two are routinely studied together.
Supplying both in one vial gives researchers a fixed 1:1 ratio, a single reconstitution step and one certificate covering both components. Laboratories that want to vary the ratio can source Ipamorelin 10mg separately.
CJC-1295 + Ipamorelin Composition
CJC-1295 without DAC (5mg)
The “No DAC” form lacks the drug-affinity-complex linker of full CJC-1295, so it behaves as a short-acting GHRH analogue in receptor and pituitary-cell studies. It is used in GHRH-receptor binding and cAMP assays and in enzyme-stability comparisons with Sermorelin. Published work can be explored on PubMed.
Ipamorelin (5mg)
Ipamorelin is studied as a selective growth hormone secretagogue that, in preclinical work, stimulates GH release from pituitary cells without a comparable effect on cortisol or prolactin.
CJC-1295 + Ipamorelin vs Sermorelin and Tesamorelin
Sermorelin and Tesamorelin are single GHRH analogues. This blend adds a ghrelin-receptor agonist, so it is chosen when the research question concerns the interaction of the two pathways rather than GHRH signalling alone.
Why Researchers Choose CJC-1295 + Ipamorelin from ThePeptideCode
- Verified purity: ≥99% by HPLC, with both peptides confirmed by mass spectrometry.
- Independent testing: every batch is tested by an ISO 17025 accredited third-party laboratory.
- Batch-specific certificates: the certificate matches the batch you receive.
- Fixed 1:1 ratio: 5mg CJC-1295 (No DAC) and 5mg Ipamorelin in every vial.
- Fast UK dispatch: in-stock items are dispatched within one working day.
- UK Express delivery: £6.99, free on orders over £100.
Quality Control and Batch Testing
Every batch of CJC-1295 + Ipamorelin is analysed before release. HPLC confirms purity, and mass spectrometry confirms that both peptides are present and correctly identified. You can view current certificates on our verification and testing page.
Storage and Handling
Store the lyophilised vial at −20°C for long-term stability, protected from light and moisture. Reconstitute with bacteriostatic water using aseptic technique, then keep the solution refrigerated at 2–8°C and use promptly. See our guides on how to reconstitute peptides and how to store research peptides.
Research Use Only
CJC-1295 + Ipamorelin is supplied strictly for in-vitro laboratory research. It is not a medicine, supplement or cosmetic product. It is not intended to diagnose, treat, cure or prevent any disease, and it is not for human or veterinary use. By purchasing, you confirm that the product will be used solely for lawful laboratory research.
CJC-1295 + Ipamorelin FAQs
What is in the CJC-1295 + Ipamorelin blend?
10mg of total peptide content: 5mg CJC-1295 without DAC and 5mg Ipamorelin, co-lyophilised in one vial.
What does “No DAC” mean?
DAC is the drug-affinity-complex linker on full-length CJC-1295 that binds albumin. The No DAC form omits it, so the peptide is the short-acting Modified GRF (1–29).
Does the blend need reconstituting?
Yes. It is supplied as lyophilised powder and should be reconstituted with bacteriostatic water before use in research protocols.
How is the CJC-1295 + Ipamorelin blend tested?
Every batch is tested to ≥99% purity by HPLC, with both peptides confirmed by mass spectrometry, at an ISO 17025 accredited third-party laboratory.
How should the blend be stored?
Keep the lyophilised vial at −20°C for long-term storage. Once reconstituted, refrigerate at 2–8°C and use promptly.
Is the CJC-1295 + Ipamorelin blend for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.